Boston (1)

Buffalo (1)

Cleveland (1)

Dallas (1)

Duarte (1)

Iowa City (1)

New York (1)

Seattle (1)

Newly Diagnosed AML With FLT3 Activating Mutations (1)

Completed (1)

phase 2 (1)

Arog Pharmaceuticals, Inc. (1)

crenolanib (1)

cytarabine (1)

daunorubicin (1)

idarubicin (1)

drug (1)

Industry (1)

Interventional (1)

newly diagnosed aml with flt3 activating mutations

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Jul 17, 2020